Mice With ALS Don’t Die
27:14–28:00 · 46s
Lane claims their device treatment keeps ALS transgenic mice alive and running if administered biweekly, projecting human dosing every 3–4 months.
27:14–28:00 · 46s
Lane claims their device treatment keeps ALS transgenic mice alive and running if administered biweekly, projecting human dosing every 3–4 months.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.